Cx Institutional Gilead Sciences, Inc. Transaction History

Cx Institutional

$2.5 Billion
Q4 2024

A detailed history of Cx Institutional transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cx Institutional holds 64,287 shares of GILD stock, worth $6.17 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

64,287

Previous 60,987 5.41%

Holding current value

$6.17 Million

Previous $5.11 Million 16.18%

% of portfolio

0.24%

Previous 0.23%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$83.95 - $97.9 $277,035 - $323,070	3,300 Added 5.41%	64,287 $5.94 Million
Q3 2024 Oct 11, 2024	BUY	$66.59 - $83.99 $1.04 Million - $1.31 Million	15,545 Added 34.21%	60,987 $5.11 Million
Q2 2024 Jul 11, 2024	SELL	$63.15 - $72.88 $154,464 - $178,264	-2,446 Reduced 5.11%	45,442 $3.12 Million
Q1 2024 Apr 15, 2024	BUY	$71.58 - $87.29 $73,297 - $89,384	1,024 Added 2.19%	47,888 $3.51 Million
Q4 2023 Jan 12, 2024	BUY	$73.27 - $83.09 $562,713 - $638,131	7,680 Added 19.6%	46,864 $3.8 Million
Q3 2023 Oct 17, 2023	SELL	$73.94 - $80.67 $1.46 Million - $1.6 Million	-19,811 Reduced 33.58%	39,184 $2.94 Million
Q2 2023 Jul 26, 2023	BUY	$76.01 - $86.7 $183,260 - $209,033	2,411 Added 4.26%	58,995 $4.55 Million
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $3.71 Million - $4.23 Million	48,011 Added 560.03%	56,584 $4.69 Million
Q4 2022 Feb 03, 2023	BUY	$62.32 - $89.47 $55,402 - $79,538	889 Added 11.57%	8,573 $735,000
Q3 2022 Nov 04, 2022	SELL	$59.54 - $68.01 $1.68 Million - $1.92 Million	-28,164 Reduced 78.57%	7,684 $474,000
Q2 2022 Aug 02, 2022	BUY	$57.72 - $65.01 $185,108 - $208,487	3,207 Added 9.83%	35,848 $2.22 Million
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $264,462 - $331,400	-4,566 Reduced 12.27%	32,641 $1.94 Million
Q4 2021 Jan 18, 2022	SELL	$64.88 - $73.64 $962,624 - $1.09 Million	-14,837 Reduced 28.51%	37,207 $2.7 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $47,383 - $51,121	700 Added 1.36%	52,044 $3.64 Million
Q2 2021 Aug 04, 2021	BUY	$63.47 - $69.35 $206,531 - $225,664	3,254 Added 6.77%	51,344 $3.54 Million
Q1 2021 Apr 15, 2021	BUY	$60.0 - $68.46 $2.78 Million - $3.17 Million	46,333 Added 2637.05%	48,090 $3.11 Million
Q4 2020 Jan 12, 2021	BUY	$56.65 - $64.55 $42,317 - $48,218	747 Added 73.96%	1,757 $102,000
Q3 2020 Oct 13, 2020	BUY	$62.1 - $78.08 $8,694 - $10,931	140 Added 16.09%	1,010 $64,000
Q2 2020 Aug 06, 2020	BUY	$72.34 - $84.0 $4,123 - $4,788	57 Added 7.01%	870 $67,000
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $26,805 - $34,334	428 Added 111.17%	813 $61,000
Q4 2019 Jan 21, 2020	SELL	$61.62 - $67.78 $29,392 - $32,331	-477 Reduced 55.34%	385 $25,000
Q3 2019 Oct 10, 2019	SELL	$62.51 - $69.0 $16,127 - $17,802	-258 Reduced 23.04%	862 $55,000
Q2 2019 Jul 17, 2019	SELL	$61.87 - $69.38 $81,049 - $90,887	-1,310 Reduced 53.91%	1,120 $76,000
Q1 2019 Apr 03, 2019	BUY	$62.53 - $70.05 $148,383 - $166,228	2,373 Added 4163.16%	2,430 $158,000
Q4 2018 Jan 14, 2019	BUY	$60.54 - $79.0 $3,450 - $4,503	57 New	57 $4,000

Others Institutions Holding GILD

# of Institutions

1,990

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.85M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $120B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.

Account

Cx Institutional Gilead Sciences, Inc. Transaction History